Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:Bundle ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "bundle-finasteride-raw"] ; # fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi> ] ) ] ; # fhir:language [ fhir:v "en"] ; # fhir:identifier [ fhir:system [ fhir:v "https://www.gravitatehealth.eu/sid/doc"^^xsd:anyURI ] ; fhir:value [ fhir:v "himss-finasteride" ] ] ; # fhir:type [ fhir:v "document"] ; # fhir:timestamp [ fhir:v "2023-06-27T10:09:22Z"^^xsd:dateTime] ; # fhir:entry ( [ fhir:fullUrl [ fhir:v "http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-finasteride"^^xsd:anyURI ] ; ( fhir:resource <http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-finasteride> ) ] [ fhir:fullUrl [ fhir:v "http://hl7.eu/fhir/ig/gravitate-health/Composition/himss-finasteride-mpd"^^xsd:anyURI ] ; ( fhir:resource <http://hl7.eu/fhir/ig/gravitate-health/Composition/himss-finasteride-mpd> ) ] ) . # <http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-finasteride> a fhir:Composition ; fhir:id [ fhir:v "composition-en-finasteride"] ; # fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi> ] ) ] ; # fhir:language [ fhir:v "en"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><a name=\"Composition_composition-en-finasteride\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Composition composition-en-finasteride</b></p><a name=\"composition-en-finasteride\"> </a><a name=\"hccomposition-en-finasteride\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.gravitatehealth.eu/sid/doc</code>/himss-finasteride</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi/ 100000155538}\">Package Leaflet</span></p><p><b>category</b>: <span title=\"Codes:{http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs R}\">Raw</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: EMA</p><p><b>title</b>: TEST PURPOSES ONLY - finasteride</p><h3>Attesters</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://hl7.org/fhir/composition-attestation-mode official}\">Official</span></td><td>2022-02-16 13:28:17+0000</td></tr></table></div>"^^rdf:XMLLiteral ] ; # fhir:identifier ( [ fhir:system [ fhir:v "https://www.gravitatehealth.eu/sid/doc"^^xsd:anyURI ] ; fhir:value [ fhir:v "himss-finasteride" ] ] ) ; # fhir:status [ fhir:v "final"] ; # fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "Package Leaflet" ] ] ; # fhir:category ( [ ( fhir:coding [ fhir:system [ fhir:v "http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs"^^xsd:anyURI ] ; fhir:code [ fhir:v "R" ] ; fhir:display [ fhir:v "Raw" ] ] ) ] ) ; # fhir:subject ( [ fhir:reference [ fhir:v "MedicinalProductDefinition/himss-finasteride-mpd" ] ] ) ; # fhir:date [ fhir:v "2022-02-16T13:28:17Z"^^xsd:dateTime] ; # fhir:author ( [ fhir:display [ fhir:v "EMA" ] ] ) ; # fhir:title [ fhir:v "TEST PURPOSES ONLY - finasteride"] ; # fhir:attester ( [ fhir:mode [ ( fhir:coding [ fhir:system [ fhir:v "http://hl7.org/fhir/composition-attestation-mode"^^xsd:anyURI ] ; fhir:code [ fhir:v "official" ] ] ) ] ; fhir:time [ fhir:v "2022-02-16T13:28:17Z"^^xsd:dateTime ] ] ) ; # fhir:section ( [ fhir:title [ fhir:v "B. Package Leaflet" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "B. Package Leaflet" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"/>"^^rdf:XMLLiteral ] ; ( fhir:section [ fhir:title [ fhir:v "Package leaflet: Information for the user" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "Package leaflet: Information for the user" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>Finasteride 5 mg film-coated tablets</h2><h2>(Finasteride)</h2><p>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.</p><ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor, pharmacist or nurse.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul> <!-- [oai_citation:0‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "What is in this leaflet" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "What is in this leaflet" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ol><li>What Finasteride is and what it is used for</li><li>What you need to know before you take Finasteride</li><li>How to take Finasteride</li><li>Possible side effects</li><li>How to store Finasteride</li><li>Contents of the pack and other information</li></ol> <!-- [oai_citation:1‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "1. What finasteride is and what it is used for" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "1. What finasteride is and what it is used for" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Finasteride contains the active substance finasteride which belongs to the group of medicines called 5-alpha reductase inhibitors. They act by reducing the size of the prostate gland in men.</p><p>Finasteride is used in the treatment and control of benign (non-cancerous) enlargement of the prostate (benign prostatic hyperplasia BPH). It reduces the risk of you developing a sudden inability to pass urine (acute urinary retention) and the need for surgery.</p> <!-- [oai_citation:2‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "2. What you need to know before you take finasteride" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "2. What you need to know before you take finasteride" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Do not take Finasteride if you:</h3><ul><li>are allergic to finasteride or any of the other ingredients (listed in section 6)</li><li>are a woman (see also under ‘Pregnancy, breast-feeding and fertility’)</li><li>are a child</li></ul> <!-- [oai_citation:3‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Warnings and precautions</h3><ul><li>reduced liver function</li><li>difficulty emptying your bladder completely or greatly reduced urine flow (exclude other urinary obstruction first)</li><li>any changes in breast tissue (lumps, pain, enlargement, nipple discharge)—report these promptly</li></ul> <!-- [oai_citation:4‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><p>If your sexual partner is or may be pregnant, avoid exposing her to your semen which could contain a tiny amount of the drug.</p> <!-- [oai_citation:5‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Mood alterations and depression</h3><p>Mood alterations such as depressed mood, depression and, less frequently, suicidal thoughts have been reported. If you experience these, contact your doctor as soon as possible.</p> <!-- [oai_citation:6‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Other medicines and Finasteride</h3><p>Finasteride does not usually interfere with other medicines. Tell your doctor or pharmacist if you are taking any other medicines.</p> <!-- [oai_citation:7‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Finasteride with food and drink</h3><p>Finasteride can be taken with or without food.</p> <!-- [oai_citation:8‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Pregnancy, breast-feeding and fertility</h3><ul><li>Finasteride is only intended for men.</li><li>Women who are or may be pregnant should not handle broken or crushed tablets—absorption may cause fetal genital malformation.</li></ul> <!-- [oai_citation:9‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Driving and using machines</h3><p>No evidence suggests Finasteride affects driving or machine use.</p> <!-- [oai_citation:10‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Finasteride contains lactose</h3><p>If you have an intolerance to some sugars, contact your doctor before taking this medicine.</p> <!-- [oai_citation:11‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Finasteride contains sodium</h3><p>This medicine contains less than 1 mmol sodium (23 mg) per tablet (essentially ‘sodium-free’).</p> <!-- [oai_citation:12‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "3. How to take finasteride" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "3. How to take finasteride" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>The recommended dose is one tablet daily (5 mg finasteride). Swallow the film-coated tablet whole; do not break or crush. It may be taken with or without food.</p> <!-- [oai_citation:13‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>If you take more Finasteride than you should</h3><p>Contact a doctor, hospital casualty department or poison centre immediately.</p> <!-- [oai_citation:14‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>If you forget to take Finasteride</h3><p>Do not take a double dose. Take the next dose when it is due.</p> <!-- [oai_citation:15‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>If you stop taking Finasteride</h3><p>Although improvement may be noticed shortly, treatment should continue for at least 6 months. Do not alter or stop without medical advice.</p> <!-- [oai_citation:16‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "4. Possible side effects" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "4. Possible side effects" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Stop using and contact your doctor immediately if you experience any of the following (angioedema):</h3><ul><li>Swelling of face, tongue or throat; difficulty swallowing; hives; breathing difficulties</li></ul> <!-- [oai_citation:17‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Common (may affect up to 1 in 10 people):</h3><ul><li>Decreased ejaculate volume</li><li>Impotence</li><li>Reduced sex drive</li></ul><h3>Uncommon (may affect up to 1 in 100 people):</h3><ul><li>Rash</li><li>Ejaculation problems that may continue after stopping</li><li>Breast swelling or tenderness</li></ul><h3>Not known (frequency cannot be estimated):</h3><ul><li>Itching, hives</li><li>Palpitations</li><li>Increased liver enzymes</li><li>Testicular pain</li><li>Male infertility or poor semen quality</li><li>Depression, anxiety</li></ul> <!-- [oai_citation:18‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Combination therapy with doxazosin</h3><p>When used with doxazosin, higher incidence of asthenia (16.8%), postural hypotension (17.8%), dizziness (23.2%) and ejaculation disorders (14.1%) versus placebo.</p> <!-- [oai_citation:19‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Reporting of side effects</h3><p>Talk to your doctor or pharmacist about any side effects. You can also report them via the Yellow Card Scheme at <a rel=\"noopener noreferrer\" href=\"https://www.mhra.gov.uk/yellowcard\" target=\"_blank\">www.mhra.gov.uk/yellowcard</a>.</p> <!-- [oai_citation:20‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "5. How to store finasteride" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "5. How to store finasteride" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Keep out of sight and reach of children.</li><li>No special storage conditions required.</li><li>Do not use after the expiry date on the label (last day of that month).</li><li>Do not dispose via wastewater or household waste; ask your pharmacist.</li></ul> <!-- [oai_citation:21‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] [ fhir:title [ fhir:v "6. Contents of the pack and other information" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi/"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000155538" ] ] ) ; fhir:text [ fhir:v "6. Contents of the pack and other information" ] ] ; fhir:text [ fhir:status [ fhir:v "additional" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>What Finasteride contains</h3><ul><li><strong>Active substance:</strong> finasteride 5 mg per film-coated tablet.</li><li><strong>Other ingredients:</strong><ul><li>Tablet core: lactose monohydrate, microcrystalline cellulose, pregelatinised starch, sodium starch glycolate, docusate sodium, magnesium stearate.</li><li>Film coating: hypromellose (E 464), titanium dioxide (E 171), indigo carmine aluminium lake (E 132), talc, iron oxide yellow (E 172).</li></ul></li></ul> <!-- [oai_citation:22‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>What Finasteride looks like and pack sizes</h3><p>Blue, round, film-coated tablets debossed ‘H’ and ‘37’. Available in blister packs of 15, 28, 30, 50, 90, 98 or 100 tablets.</p> <!-- [oai_citation:23‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Marketing Authorisation Holder and Manufacturer</h3><p><strong>Marketing Authorisation Holder:</strong></p><p>Amarox Limited, Congress House, 14 Lyon Road, Harrow, Middlesex HA1 2EN, United Kingdom</p><p><strong>Manufacturer:</strong></p><p>Pharmadox Healthcare Ltd, Kordin Industrial Park, Paola PLA 3000, Malta</p><p>or</p><p>Amarox Limited, Congress House, 14 Lyon Road, Harrow, Middlesex HA1 2EN, United Kingdom</p> <!-- [oai_citation:24‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><h3>Authorisations in the EEA</h3><ul><li>Germany: Finasterid Amarox 5 mg Filmtabletten</li><li>Denmark: Finasterid Amarox 5 mg Filmovertrukne tabletter</li><li>France: Finasteride Amarox 5 mg comprimé pelliculé</li><li>Spain: Finasterida Tarbis 5 mg comprimidos recubiertos con película EFG</li><li>Italy: Finasterida Amarox</li><li>Netherlands: Finasteride Amarox 5 mg filmomhulde tabletten</li><li>Portugal: Finasterida Amarox</li><li>Sweden: Finasteride Amarox 5 mg Filmdragerad tablett</li><li>United Kingdom: Finasteride 5 mg film-coated tablets</li></ul> <!-- [oai_citation:25‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --><p>This leaflet was last revised in 09/2021.</p> <!-- [oai_citation:26‡pil.13543.pdf](file-service://file-JCS7gTrRt25FFSUPp8bKGr) --></div>"^^rdf:XMLLiteral ] ] ) ] ) . # <http://hl7.eu/fhir/ig/gravitate-health/Composition/himss-finasteride-mpd> a fhir:MedicinalProductDefinition ; fhir:id [ fhir:v "himss-finasteride-mpd"] ; # fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"^^xsd:anyURI ; fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi> ] ) ] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_himss-finasteride-mpd\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition himss-finasteride-mpd</b></p><a name=\"himss-finasteride-mpd\"> </a><a name=\"hchimss-finasteride-mpd\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html\">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.gravitatehealth.eu/sid/doc</code>/himss-finasteride</p><p><b>type</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}\">Medicinal Product</span></p><p><b>domain</b>: <span title=\"Codes:{http://hl7.org/fhir/medicinal-product-domain Human}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{http://hl7.org/fhir/publication-status active}\">active</span></p><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/rmswi 100000072084}\">Medicinal product subject to medical prescription</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: finasteride Flexpen 100 units/ml solution for injection in pre-filled pens</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000001}\">Full name</span></p><blockquote><p><b>part</b></p><p><b>part</b>: finasteride FlexPen</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000002}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Insulin</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000003}\">Scientific name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 100 units/ml</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: solution for injection in pre-filled pens</p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 GBR}\">United Kingdom</span></td><td><span title=\"Codes:{urn:iso:std:iso:3166 GBR}\">United Kingdom</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 en}\">English</span></td></tr></table></blockquote></div>"^^rdf:XMLLiteral ] ; # fhir:identifier ( [ fhir:system [ fhir:v "https://www.gravitatehealth.eu/sid/doc"^^xsd:anyURI ] ; fhir:value [ fhir:v "himss-finasteride" ] ] ) ; # fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "http://hl7.org/fhir/medicinal-product-type"^^xsd:anyURI ] ; fhir:code [ fhir:v "MedicinalProduct" ] ; fhir:display [ fhir:v "Medicinal Product" ] ] ) ] ; # fhir:domain [ ( fhir:coding [ fhir:system [ fhir:v "http://hl7.org/fhir/medicinal-product-domain"^^xsd:anyURI ] ; fhir:code [ fhir:v "Human" ] ; fhir:display [ fhir:v "Human use" ] ] ) ] ; # fhir:status [ ( fhir:coding [ fhir:system [ fhir:v "http://hl7.org/fhir/publication-status"^^xsd:anyURI ] ; fhir:code [ fhir:v "active" ] ; fhir:display [ fhir:v "active" ] ] ) ] ; # fhir:legalStatusOfSupply [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi"^^xsd:anyURI ] ; fhir:code [ fhir:v "100000072084" ] ; fhir:display [ fhir:v "Medicinal product subject to medical prescription" ] ] ) ] ; # fhir:name ( [ fhir:productName [ fhir:v "finasteride Flexpen 100 units/ml solution for injection in pre-filled pens" ] ; fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/lists/220000000000"^^xsd:anyURI ] ; fhir:code [ fhir:v "220000000001" ] ; fhir:display [ fhir:v "Full name" ] ] ) ] ; ( fhir:part [ fhir:part [ fhir:v "finasteride FlexPen" ] ; fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/lists/220000000000"^^xsd:anyURI ] ; fhir:code [ fhir:v "220000000002" ] ; fhir:display [ fhir:v "Invented name part" ] ] ) ] ] [ fhir:part [ fhir:v "Insulin" ] ; fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/lists/220000000000"^^xsd:anyURI ] ; fhir:code [ fhir:v "220000000003" ] ; fhir:display [ fhir:v "Scientific name part" ] ] ) ] ] [ fhir:part [ fhir:v "100 units/ml" ] ; fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/lists/220000000000"^^xsd:anyURI ] ; fhir:code [ fhir:v "220000000004" ] ; fhir:display [ fhir:v "Strength part" ] ] ) ] ] [ fhir:part [ fhir:v "solution for injection in pre-filled pens" ] ; fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://spor.ema.europa.eu/lists/220000000000"^^xsd:anyURI ] ; fhir:code [ fhir:v "220000000005" ] ; fhir:display [ fhir:v "Pharmaceutical dose form part" ] ] ) ] ] ) ; ( fhir:usage [ fhir:country [ ( fhir:coding [ fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ; fhir:code [ fhir:v "GBR" ] ; fhir:display [ fhir:v "United Kingdom" ] ] ) ] ; fhir:jurisdiction [ ( fhir:coding [ fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ; fhir:code [ fhir:v "GBR" ] ; fhir:display [ fhir:v "United Kingdom" ] ] ) ] ; fhir:language [ ( fhir:coding [ fhir:system [ fhir:v "urn:ietf:bcp:47"^^xsd:anyURI ] ; fhir:code [ fhir:v "en" ] ; fhir:display [ fhir:v "English" ] ] ) ] ] ) ] ) . #
IG © 2021+ Gravitate Health Project. Package hl7.eu.fhir.gh#0.1.0 based on FHIR 5.0.0. Generated 2025-07-25
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
